®

: Paclitaxel Teva ®. ?  »
|
-

I.V

Concentrate For Solution For Infusion

Ovarian carcinoma : Paclitaxel Teva is indicated alone or in combination for the treatment of advanced carcinoma of the ovary. Breast carcinoma : Paclitaxel Teva is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin - containing combination chemotherapy. Paclitaxel Teva is indicated for the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Advanced non small cell lung cancer : Paclitaxel Teva associated with cisplatium is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Kaposis sarcoma : Paclitaxel Teva is indicated in the second- line treatment of AID`S related Kaposi`s sarcoma. Gastric carcinoma : Paclitaxel Teva for the treatment of advanced gastric carcinoma.

136 41 31278 00

Pharmachemie Bv, Holland (teva Group)

02/2012 - 02/2022

.
, .
.
/
Paclitaxel 6 MG/ML
Vial glass type i 1 x 5 ML 24
Vial glass type i 1 x 16.7 ML 24
Vial glass type i 1 x 50 ML 24

*

*

 

.

 
" !
 
301
-